- Oral aciclovir given early in primary herpes gingivostomatitis has been shown to reduce duration of symptoms, improve healing of oral lesions and reduce infectivity of affected individuals. (Grade B)
- Current evidence supports the use of oral aciclovir (15 mg/kg/five times a day for 7 days) in cases of primary herpes gingivostomatitis in
. . . [Full text of this article]
ARCHIMEDES
QUESTION 1
Childrens Hospital for Wales, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK; hudsonbe@hotmail.com
University Hospital of Wales, Cardiff, UK
| The first 150 words of the full text of this article appear below. |
DOES ORAL ACICLOVIR IMPROVE CLINICAL OUTCOME IN IMMUNOCOMPETENT CHILDREN WITH PRIMARY HERPES SIMPLEX GINGIVOSTOMATITIS?
A 3-year-old previously well boy presents with a fever of 38.6°C and several ulcers and erosions extending from his lips, along the tongue and cheek, to the back of the throat. The lesions have all appeared within the last 2 days. He has been crying inconsolably over the past 24 h and is refusing food and drink. Considering the current evidence we question whether the use of oral aciclovir is indicated for primary herpes gingivostomatitis in children.
In an immunocompetent child presenting with primary herpes simplex gingivostomatitis [patient], does oral aciclovir [intervention] reduce the duration of symptoms [outcome]?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



